Change of Name

Recorded: 2024-08-12 Pages: 18

Assignor

ARROWHEAD RESEARCH CORPORATION

Executed: 2016-04-05

Assignee

ARROWHEAD PHARMACEUTICALS, INC.

225 SOUTH LAKE AVENUE, SUITE 1050, PASADENA, CALIFORNIA, 91101

Covered Properties (2)

RNAi-RELATED INHIBITION OF TNFa SIGNALING PATHWAY FOR TREATMENT OF OCULAR ANGIOGENESIS

Patent: 8,754,202 →

Application: 13/169,549 →

Publication: US US20110257248A1

RNAi-RELATED INHIBITION OF TNF alpha SIGNALING PATHWAY FOR TREATMENT OF OCULAR ANGIOGENESIS

Patent: 9,139,834 →

Application: 14/270,197 →

Publication: US US20140357696A1

Related Assignments (2)

Other recorded transfers of the patents in this record — the chain of ownership.